These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28132934)

  • 21. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
    Bachhav YG; Heinrich A; Kalia YN
    Eur J Pharm Biopharm; 2013 Jun; 84(2):355-64. PubMed ID: 23207321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
    Prausnitz MR
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elongate microparticles for enhanced drug delivery to ex vivo and in vivo pig skin.
    Raphael AP; Primiero CA; Ansaldo AB; Keates HL; Soyer HP; Prow TW
    J Control Release; 2013 Nov; 172(1):96-104. PubMed ID: 23933236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microneedle roller is an effective device for enhancing transdermal drug delivery.
    Li K; Yoo KH; Byun HJ; Lim YY; Kim MN; Hong HK; Choi YS; Jo YC; Kim BJ
    Int J Dermatol; 2012 Sep; 51(9):1137-9. PubMed ID: 22233171
    [No Abstract]   [Full Text] [Related]  

  • 26. Coated microneedles for transdermal delivery.
    Gill HS; Prausnitz MR
    J Control Release; 2007 Feb; 117(2):227-37. PubMed ID: 17169459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin drug permeability and safety through a vibrating solid micro-needle system.
    Liu TT; Chen K; Wang Q
    Drug Deliv Transl Res; 2018 Oct; 8(5):1025-1033. PubMed ID: 29858819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controllable coating of microneedles for transdermal drug delivery.
    Chen J; Qiu Y; Zhang S; Yang G; Gao Y
    Drug Dev Ind Pharm; 2015 Mar; 41(3):415-22. PubMed ID: 24378200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Design of transdermal ultrasonophoresis equipment].
    Li L; Zhang Y; Li Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):184-6. PubMed ID: 19334582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling transdermal delivery of high molecular weight drugs from microneedle systems.
    Al-Qallaf B; Das DB; Mori D; Cui Z
    Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2951-67. PubMed ID: 17890186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of cup shaped microneedle array for transdermal drug delivery.
    Vinayakumar KB; Hegde GM; Ramachandra SG; Nayak MM; Dinesh NS; Rajanna K
    Biointerphases; 2015 Jun; 10(2):021008. PubMed ID: 25956180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends.
    Perumal O; Murthy SN; Kalia YN
    Skin Pharmacol Physiol; 2013; 26(4-6):331-42. PubMed ID: 23921120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal delivery of insulin using microneedle rollers in vivo.
    Zhou CP; Liu YL; Wang HL; Zhang PX; Zhang JL
    Int J Pharm; 2010 Jun; 392(1-2):127-33. PubMed ID: 20347024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcutaneous drug delivery by liposomes using fractional laser technology.
    Fujimoto T; Wang J; Baba K; Oki Y; Hiruta Y; Ito M; Ito S; Kanazawa H
    Lasers Surg Med; 2017 Jul; 49(5):525-532. PubMed ID: 27990655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A microarray MEMS device for biolistic delivery of vaccine and drug powders.
    Pirmoradi FN; Pattekar AV; Linn F; Recht MI; Volkel AR; Wang Q; Anderson GB; Veiseh M; Kjono S; Peeters E; Uhland SA; Chow EM
    Hum Vaccin Immunother; 2015; 11(8):1936-44. PubMed ID: 26090875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Microbubble Size on Ultrasound-Induced Transdermal Delivery of High-Molecular-Weight Drugs.
    Liao AH; Ho HC; Lin YC; Chen HK; Wang CH
    PLoS One; 2015; 10(9):e0138500. PubMed ID: 26390051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk.
    Lee WR; Shen SC; Aljuffali IA; Lin YK; Huang CW; Fang JY
    Eur J Pharm Sci; 2016 Sep; 92():1-10. PubMed ID: 27345564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Design and manufacture of microneedles array for transdermal drug delivery].
    Zhang JY; Zhao YJ; Yang XL
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Jan; 30(1):33-8. PubMed ID: 16646423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis.
    Choi EH; Lee SH; Ahn SK; Hwang SM
    Skin Pharmacol Appl Skin Physiol; 1999; 12(6):326-35. PubMed ID: 10545829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.